Unison Medicines is delighted to announce an oversubscribed first close of $500k of financing from a syndicate of highly sophisticated biopharma angels. Unison will use the proceeds to conduct a series of animal studies of [...]
More news
After receiving over 40 impressive applications and conducting a rigorous selection process, we are ready [...]
December 16, 2024 – INCATE (the INCubator for Antibacterial Therapies in Europe), is delighted to [...]
December 16, 2024 – INCATE (INCubator for Antibacterial Therapies in Europe) is pleased to announce [...]
Just before turning the page to 2025, it's a moment to reflect on the progress [...]
We are thrilled to announce a significant milestone for Invitris—a $650,000 deal plus royalties with [...]
2024 has been a transformative year for Xiretsa, filled with exciting milestones and promising opportunities. [...]
INCATE is pleased to invite researchers, clinicians, and industry experts to submit articles for an [...]
Kinzbio’s mission is to harness the power of phages—nature's precision antimicrobials—to address some of the [...]
